In stomach adenocarcinoma (STAD), POLD1-mutant tumors exhibit significantly higher PD-L1 mRNA expression compared to wild-type tumors (P=0.0072), indicative of adaptive immune resistance (61). The gene discussed is CD274; the disease is gastric adenocarcinoma.